TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
SVAR Life Science AB
Closing information (x1000 EUR)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
24,633
|
25,475
|
23,884 |
| Financial expenses |
456
|
1,035
|
728 |
| Earnings before taxes |
5,197
|
4,248
|
4,067 |
| EBITDA |
5,672
|
4,501
|
4,294 |
| Total assets |
33,691
|
28,341
|
25,141 |
| Current assets |
24,376
|
19,993
|
15,635 |
| Current liabilities |
5,797
|
5,211
|
5,278 |
| Equity capital |
24,564
|
21,124
|
17,493 |
| - share capital |
26
|
26
|
26 |
| Employees (average) |
121
|
122
|
120 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
72.9%
|
74.5%
|
69.6% |
| Turnover per employee |
204
|
209
|
199 |
| Profit as a percentage of turnover |
21.1%
|
16.7%
|
17.0% |
| Return on assets (ROA) |
16.8%
|
18.6%
|
19.1% |
| Current ratio |
420.5%
|
383.7%
|
296.2% |
| Return on equity (ROE) |
21.2%
|
20.1%
|
23.2% |
| Change turnover |
24
|
1,522
|
3,944 |
| Change turnover % |
0%
|
6%
|
20% |
| Chg. No. of employees |
-1
|
2
|
-3 |
| Chg. No. of employees % |
-1%
|
2%
|
-2% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.